Synonyms:ENTACAPONE, 130929-57-6, Comtan, Comtess, Entacaponum, OR-611, Entacapona, (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide, 116314-67-1, Entacapone teva, Entacapone orion, (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide, (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide, (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide, CHEMBL953, 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, CHEBI:4798, DTXSID5046439, 2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide, N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide, 4975G9NM6T, (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide, Entacaponum [INN-Latin], Entacapona [INN-Spanish], NCGC00164555-01, Entacom, 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (2E)-, DTXCID3026439, OR 611, (E)-Entacapone, (~{E})-2-cyano-~{N},~{N}-diethyl-3-[3-nitro-4,5-bis(oxidanyl)phenyl]prop-2-enamide, Comtan (TN), CAS-130929-57-6, SR-05000001452, (E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide, UNII-4975G9NM6T, COM-998, Entacapone [USAN:USP:INN:BAN], ENTACAPONE [MI], ENTACAPONE [INN], ENTACAPONE [JAN], ENTACAPONE [USAN], (E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide, ENTACAPONE [VANDF], ENTACAPONE [MART.], ENTACAPONE [USP-RS], ENTACAPONE [WHO-DD], SCHEMBL34504, SCHEMBL34505, BIDD:GT0026, ENTACAPONE [EMA EPAR], 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-n,n-diethyl-2-propenamide, Entacapone (JP17/USP/INN), GTPL6647, ENTACAPONE [ORANGE BOOK], SCHEMBL13596593, HSDB 8251, ENTACAPONE [EP MONOGRAPH], ENTACAPONE [USP MONOGRAPH], HMS2089O16, HMS3713B20, HMS3885K09, OR611, STALEVO COMPONENT ENTACAPONE, CORBILTA COMPONENT ENTACAPONE, EX-A1130, Tox21_112184, AC-393, BDBM50108879, MFCD00866580, s3147, AKOS015907685, AKOS015965009, ENTACAPONE COMPONENT OF STALEVO, Tox21_112184_1, BCP9000645, CCG-213064, CS-1266, DB00494, ENTACAPONE COMPONENT OF CORBILTA, NCGC00164555-02, NCGC00164555-03, NCGC00164555-10, HY-14280, E0961, SW199035-2, C07943, D00781, AB01275450-01, AB01275450_02, AB01275450_03, A806167, A922031, Q416444, J-005902, J-008069, SR-05000001452-1, SR-05000001452-2, SR-05000001452-3, BRD-K83636919-001-01-4, LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT ENTACAPONE, (E)-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide, ENTACAPONE COMPONENT OF LEVODOPA/CARBIDOPA/ENTACAPONE ORION, (E)-.ALPHA.-CYANO-N,N-DIETHYL-3,4-DIHYDROXY-5-NITROCINNAMAMIDE, (E)-N, N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide, (E)-2-cyano-N,N-diethyl-3-[3-nitro-4,5-bis(oxidanyl)phenyl]prop-2-enamide, 2-Propenamide,2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-,(2E)-, PD9
Pubchem:PUBCHEM:5281081
Id:a4d6f255-2f70-518e-b4a9-d97a091c6c14
Description:nan
